RxDoctor Payments Data

Patricia Thorpe, MD

Vascular & Interventional Radiology · Phoenix, AZNPI 1851427512

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Boston Scientific at 53.7% of the total. Reporting peaked in 2019 at $8,125 and has fallen 96.4% since, to $295 in 2025.

$13,116in general payments, 2019–2025

Across 83 payments — averaging $158.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Philips North America LLC$2K
  • Veryan Medical Incorporated$831
  • Provisio Medical, Inc.$500
  • Medtronic$409
  • Venclose Inc.$391
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$7,25055%
  • Speaking & faculty fees$9007%
  • Travel & lodging$6865%
  • Food & beverage$4,28133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,116 in reported general payments places this provider in the 75th percentile of 80 vascular & interventional radiology providers in Arizona.

See all vascular & interventional radiology providers in Arizona

Medicare billing

Part B allowed, 2024
$16,781
Medicare patients
22
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$31,383
Warfarin Sodium103$556

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →